Technology driven biopharma player with differentiated portfolio and global presence

Ranked one of the fastest growing and 12th largest pharma player in India
(* as per AIOCD-AWACS March 2021)

Developing India’s first indigenous mRNA vaccine for
Covid-19

Committed to ensure dedicated support in the fight against
COVID-19

Committed to ensure dedicated support in the fight against COVID-19

Know More

Emcure Pharmaceuticals Limited was built with the purpose and core belief of making Effective Medicines to Cure patients enabling them to lead healthier lives

We are a fast-growing Indian pharmaceutical company engaged in developing, manufacturing, and marketing a broad range of biopharmaceutical products globally. Emcure’s differentiated product portfolio lends an unparalleled competitive advantage establishing its presence in all major therapies in the domestic market. With a presence in over 70 countries, Emcure’s goal is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

icons
12th Largest Pharma Company in India
icons
9,000+ Employees
icons
70+ Countries with presence

Focus Areas

Established presence in key therapeutic areas

Gynaecology
Cardiology
Anti-infective
Vitamins, minerals and nutrients
Diabetes
Anti-Retro Virals
Biologics
mRNA vaccine

Research and Development

Leveraging technology as the key differentiator in the mission to develop products that serve across diverse markets. Emcure’s in-house research and development capabilities span both chemistry and biologics providing a unique synergy to develop innovative solutions

Empowered by the strength of ~500 qualified scientists ably led by industry stalwarts: Dr Mukund Gurjar, Dr Sanjay Singh and Dr Deepak Gondaliya

Presence across 5 dedicated facilities focused towards API, formulation and biotechnology research

Read more

Newsroom

January 14, 2022

With an investment of Rs 1.5 crore, AAS Vidyalaya grabs highest deal on Shark Tank India

January 14, 2022

Conversational AI platform ORAI raises capital

January 13, 2022

Dozen IPOs likely to raise Rs 16,000 crore in March quarter

January 12, 2022

EXPLAINED: The Whys And Hows Of India's Decision To Go For A Third Covid-19 Vaccine Dose

January 12, 2022

Lenskart CEO Peyush Bansal Apologizes To CA Community Over His Remarks On 'Shark Tank'

January 12, 2022

Lenskart CEO Peyush Bansal Apologizes To CA Community Over His Remarks On 'Shark Tank'

Placeholder Image

Life at Emcure

At Emcure, we believe that the success and growth of the company is in the hands of our people. Hence, we are committed towards nurturing talent and providing equal opportunities for their further development.

Join us
Placeholder Image

Uncondition Yourself

Women’s Health continues to be a topic discussed in hushed tones with irrational stigmas and taboos associated with it. This platform aims to share real-life experiences, break myths & taboos and highlight facts, to change the dismal statistics around women’s health.

explore